Clinical Trial: A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives

U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07414784) titled 'A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives' on Feb. 11.

Brief Summary: This Study of ABBV-295 subcutaneous injections will assess pharmacokinetics and adverse events in healthy adult women participants with overweight or obesity taking oral contraceptives.

Study Start Date: Feb. 11

Study Type: INTERVENTIONAL

Condition: Healthy Volunteer

Intervention: DRUG: ABBV-295

Subcutaneous Injections

DRUG: Levonorgestrel/Ethinyl Estradiol

Oral Tablet

Recruitment Status: RECRUITING

Sponsor: AbbVie

P...